Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger and BTB domain-containing protein 25 (ZBTB25) is a transcriptional repressor belonging to the broad complex, tram track, bric-a-brac/poxvirus and zinc finger (BTB/POZ) family of transcription factors[1]. It contains a DNA-binding zinc finger motif at its C-terminus and a protein-binding BTB/POZ domain at the N-terminus, mediating both protein–DNA and protein–protein interactions[1]. ZBTB25 forms part of corepressor complexes, such as those with histone deacetylase 1 (HDAC1) and Sin3a, to actively repress transcription at specific gene promoters—particularly interleukin-12B (IL-12B)—with important roles in immune regulation during infection (e.g., *Mycobacterium tuberculosis*)[1]. Suppression of ZBTB25 derepresses immune gene expression and induces autophagy, providing a rationale for its pursuit as a host-directed therapy target in tuberculosis[1]. It also interacts with viral polymerase complexes, such as the influenza A viral RNA-dependent RNA polymerase (RdRp), where it enhances viral RNA synthesis and suppresses the host interferon response, making it a potential target for antiviral intervention[2]. Compounds such as disulfiram and specialized zinc-ejectors (e.g., DP) can inactivate ZBTB25 by targeting its zinc finger domain, inhibiting its function and disrupting its roles in infection and viral replication[1][2]. Members of the ZBTB family, including ZBTB25, have broader implications in cancer and immune disease due to their general epigenetic and immune regulatory activities[1].
Zinc finger domain ejection/inhibition (loss of protein function via zinc removal), Inhibition of transcriptional repression, Interference with protein–protein and protein–nucleic acid interactions
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger and BTB domain-containing protein 25 (ZBTB25).